FindTrial
Sign In

Comparing Oral and Topical Minoxidil with PRP for Treating Male Pattern Baldness

A Comparative Study between Oral Administration of 2.5 mg Minoxidil and Topical Application of 5 percent Minoxidil in Conjunction with Autologous Platelet-Rich Plasma for the Treatment of Male Androgenetic Alopecia - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097307
Enrollment
50
Registered
2025-11-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L648- Other androgenic alopecia

Interventions

Intervention1: Oral Administration of 2.5 mg Minoxidil and Topical Application of 5% Minoxidil: Oral Administration of 2.5 mg Minoxidil in group A and Topical Application of 5% Minoxidil in group B w

Sponsors

Datta Meghe Institute of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male patients aged 18 to 50 years 2.Clinically diagnosed of patients of AGA classified according to Hamilton Norwood stage II to V 3.No treatment taken for hair loss topical, oral or procedural in the past 1 month. 4.Willing to provide informed consent to comply with all aspects of the study protocol.

Exclusion criteria

Exclusion criteria: 1.Patients with scarring alopecia or other forms of hair loss e.g. alopecia areata, telogen effluvium. 2.Patients who are a known case of Coagulopathies or on anticoagulant,antiplatelet therapies. 3.Active scalp infections or any scalp dermatoses. 4.Use of immunosuppressive or hormonal therapies. 5.Severe co morbidities like Cardiovascular or endocrine disorders ,uncontrolled diabetes, renal or hepatic disorders. 6.Known hypersensitivity to minoxidil or PRP constituents. 7.Seropositivity for HIV, Hepatitis B, or Hepatitis C

Design outcomes

Primary

MeasureTime frame
To measure the hair shaft diameter and Hair density in both groups ,will be assessed at baseline and every 4 weekly using Tricoscopy.Timepoint: Assessment will be done in 4 months.—

Secondary

MeasureTime frame
To assess the patient satisfaction by using a standardized 5 point Likert scale .Timepoint: Assessment will be done in 4 months.—

Countries

India

Contacts

Public ContactLamiya Latheef Rawther

Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research

alsingh1969@gmail.com9765404086

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026